Rilutek is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Covis Pharma. The primary component is Riluzole.
Product ID | 70515-700_6ddc26d7-a6fe-46dd-8b49-c55aa111f83e |
NDC | 70515-700 |
Product Type | Human Prescription Drug |
Proprietary Name | Rilutek |
Generic Name | Riluzole |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2016-08-01 |
Marketing Category | NDA / NDA |
Application Number | NDA020599 |
Labeler Name | Covis Pharma |
Substance Name | RILUZOLE |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Benzothiazole [EPC],Benzothiazoles [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2016-08-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020599 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-08-01 |
Ingredient | Strength |
---|---|
RILUZOLE | 50 mg/1 |
SPL SET ID: | 6ddc26d7-a6fe-46dd-8b49-c55aa111f83e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
70515-700 | Rilutek | riluzole |
10094-350 | EXSERVAN | riluzole |
70510-2201 | Exservan | riluzole |
70510-2202 | Exservan | riluzole |
0378-4145 | Riluzole | riluzole |
42291-775 | Riluzole | riluzole |
60505-3285 | RILUZOLE | RILUZOLE |
62756-538 | Riluzole | Riluzole |
64980-191 | Riluzole | riluzole |
67877-286 | Riluzole | Riluzole |
68084-908 | RILUZOLE | RILUZOLE |
68462-381 | riluzole | riluzole |
69076-200 | Riluzole | riluzole |
69076-611 | Riluzole | Riluzole |
70726-0303 | TIGLUTIK | Riluzole |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RILUTEK 74451450 1866694 Live/Registered |
COVIS PHARMA B.V. 1993-10-26 |